SandboxAQ

SandboxAQ is an enterprise AI company that develops Large Quantitative Models (LQMs) spanning two distinct domains: Healthcare diagnostics and cybersecurity. The company has secured a definitive agreement for a $500 million CHIPS Act R&D award and plans to bring its LQMs to Google Cloud's Marketplace, signaling both governmental confidence and commercial ambition.

Healthcare: Cardiac Diagnostics with Mayo Clinic

SandboxAQ's most visible clinical initiative is its multi-stage collaboration with Mayo Clinic on AI-powered cardiac diagnostics. The partnership, announced as a novel cardiac diagnostics program, has since expanded specifically into amyloidosis detection — a condition notoriously difficult to diagnose through conventional imaging. According to SandboxAQ's press materials, the collaboration combines quantum sensing technology with AI to improve diagnostic accuracy in cardiac imaging.

The clinical work remains in a research and testing phase. SandboxAQ and Mayo Clinic have not yet published peer-reviewed outcomes or regulatory filings, which limits independent assessment of diagnostic performance. Prospective adopters should treat the technology as investigational until validated results emerge. In the broader diagnostic landscape, tools like Omogle and AuDHD Test serve different screening needs, highlighting the specialized nature of SandboxAQ's cardiac imaging focus.

Security: AQtive Guard and the AI Agent Threat

On the cybersecurity side, SandboxAQ launched AQtive Guard, a fully managed, cloud-delivered platform addressing what the company describes as an escalating threat landscape driven by billions of AI agents. The platform provides visibility into non-human identities and cryptographic inventories, and integrates with CrowdStrike Falcon — SandboxAQ's deepest technical integration to date — as well as Palo Alto Networks.

AQtive Guard launched with a priority access program, positioning it as an early-market product. The CrowdStrike integration enables joint customers to surface cryptographic vulnerabilities within their existing Falcon workflows. However, independent benchmarks, customer case studies, and long-term reliability data are not yet publicly available.

Strategic Positioning

SandboxAQ has also formed a strategic alliance with Deloitte to help enterprise clients transition securely to the quantum era. This partnership, combined with the CHIPS Act award and Google Cloud Marketplace presence, suggests the company is building institutional credibility ahead of product maturity.

What to Watch

SandboxAQ's strength lies in the caliber of its partnerships and the breadth of its technology ambitions. The main risk is the gap between announced collaborations and proven, generally available products. Clinical validation for cardiac diagnostics is pending. AQtive Guard's threat model — AI agents as a distinct attack surface — is a vendor-defined category that has not been independently validated by the broader security community. Pricing across all products remains undisclosed.

For enterprise security teams evaluating cryptographic posture management, or clinical research groups exploring AI-assisted cardiac imaging, SandboxAQ warrants monitoring. For organizations requiring mature, independently benchmarked solutions today, the company's products remain early-stage.